Search research articles
Contact Us
Filters
Showing results (151-160 of 512) with videos related to
Page
of 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers
Giannis Mountzios, David Planchard, Benjamin Besse, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2015
CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients
Fayçal Djenidi, Julien Adam, Aïcha Goubar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
Can radiation-recall predict long lasting response to immune checkpoint inhibitors?
Eric Deutsch, Benjamin Besse, Jérôme Le Pavec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2010
Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer
Jean-Charles Soria, Egbert Smit, David Khayat, et al.
Frontiers in Immunology
|
February 1, 2024
HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker
Karim Amrane, Coline Le Meur, Benjamin Besse, et al.
Plos One
|
August 23, 2017
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
Cécile Jovelet, Jordan Madic, Jordi Remon, et al.
Journal of Thoracic Disease
|
June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?
Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.
Journal of Personalized Medicine
|
June 2, 2021
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
Jose Carlos Benitez, Marc Campayo, Tania Díaz, et al.
Acta Cytologica
|
December 5, 2012
Circulating tumor cells in lung cancer
Rachel Young, Emma Pailler, Fanny Billiot, et al.
Bulletin Du Cancer
|
December 5, 2014
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors]
Capucine Baldini, Boris Duchemann, Antoine Hollebecque, et al.
Page
of 52
Search research articles
Search
Showing results (151-160 of 512) with videos related to
Sort By:
Page
of 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2008
Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers
Giannis Mountzios, David Planchard, Benjamin Besse, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2015
CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients
Fayçal Djenidi, Julien Adam, Aïcha Goubar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
Can radiation-recall predict long lasting response to immune checkpoint inhibitors?
Eric Deutsch, Benjamin Besse, Jérôme Le Pavec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2010
Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer
Jean-Charles Soria, Egbert Smit, David Khayat, et al.
Frontiers in Immunology
|
February 1, 2024
HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker
Karim Amrane, Coline Le Meur, Benjamin Besse, et al.
Plos One
|
August 23, 2017
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer
Cécile Jovelet, Jordan Madic, Jordi Remon, et al.
Journal of Thoracic Disease
|
June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?
Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.
Journal of Personalized Medicine
|
June 2, 2021
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
Jose Carlos Benitez, Marc Campayo, Tania Díaz, et al.
Acta Cytologica
|
December 5, 2012
Circulating tumor cells in lung cancer
Rachel Young, Emma Pailler, Fanny Billiot, et al.
Bulletin Du Cancer
|
December 5, 2014
[Focus on targeting the Ras-MAPK pathway: the Mek inhibitors]
Capucine Baldini, Boris Duchemann, Antoine Hollebecque, et al.
Page
of 52